Definium Therapeutics Inc. Common Shares vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.58 (market cap $132.18B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 28.1× Definium Therapeutics Inc. Common Shares's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days on average.
| DFTX | MFG | |
|---|---|---|
Market Cap | $4.71B | $132.18B |
Volume | 1,966,636 | 3,264,662 |
Sector | Health | Financials |
52-Week High | $48.45 | $11.45 |
52-Week Low | $10.68 | $6.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $35.48T |
Dividend Yield | — | 1.7% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →